ZC3HAV1 and neoplasm: PARP13 emerged as the most crucial for CRC sensitivity to IR treatment in vitro, serving as a keystone regulating ISG immune response in both nonirradiated or IR treated cells, and is the most significant discriminator between tumor and healthy tissues.